PRA Health Sciences, Inc. provided earnings guidance for the first quarter and full year of 2020. For the first quarter, the company expects to achieve total revenues between $765.0 million and $787.0 million, representing as reported and constant currency growth of 6% to 9%. The Company expects GAAP net income per diluted share of between $0.59 and $0.69 per share. For the full year, the company expects to achieve total revenues between $3.23 billion and $3.36 billion, representing as reported and constant currency growth of 5.0% to 9.5%. The company expects GAAP net income per diluted share of between $4.01 and $4.21 per share.